Pine Pharmaceuticals, LLC recalls Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded
Recalled January 11, 2023 · FDA recall D-0130-2023 · Pine Pharmaceuticals
Hazard
CGMP Deviations: Raw material recalled by repackager, due to discoloration. · FDA Class II
Units
11,453 vials
Sold at
Nationwide to medical facilities.
Description
CGMP Deviations: Raw material recalled by repackager, due to discoloration.
Product
Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine Pharmaceuticals, 355 Riverwalk Pkwy, Tonawanda, NY 14150. NDC 69194-0948-1
Manufacturer(s)
Pine Pharmaceuticals, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →